Search

Your search keyword '"Bansal-Travers, Maansi"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Bansal-Travers, Maansi" Remove constraint Author: "Bansal-Travers, Maansi" Region united states Remove constraint Region: united states
122 results on '"Bansal-Travers, Maansi"'

Search Results

1. Support for pictorial health warning labels on cigarette packages in the United States among adults who currently smoke or quit smoking: Findings from the ITC US Smoking and Vaping Surveys.

3. Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury ('EVALI').

4. Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys.

5. Indicators of dependence and efforts to quit vaping and smoking among youth in Canada, England and the USA.

6. E-Cigarette Flavors, Devices, and Brands Used by Youths Before and After Partial Flavor Restrictions in the United States: Canada, England, and the United States, 2017‒2020.

7. Menthol and Mint Cigarettes and Cigars: Initiation and Progression in Youth, Young Adults and Adults in Waves 1-4 of the PATH Study, 2013-2017.

8. Longitudinal pathways of exclusive and polytobacco hookah use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

9. Correlates of tobacco product reuptake and relapse among youth and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

10. Longitudinal pathways of exclusive and polytobacco smokeless use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

11. Longitudinal pathways of exclusive and polytobacco cigar use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

12. Correlates of tobacco product cessation among youth and adults in the USA: findings from the PATH Study Waves 1-3 (20132016).

13. Initiation of any tobacco and five tobacco products across 3 years among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

14. Longitudinal pathways of exclusive and polytobacco cigarette use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

15. Correlates of tobacco product initiation among youth and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

16. Overview of tobacco use transitions for population health.

17. Menthol, Nicotine, and Flavoring Content of Capsule Cigarettes in the US.

18. Menthol Cigarettes and Smoking Cessation among Adult Smokers in the US.

19. Worry about Lung Cancer is Related to Numeracy and Risk Perception of Diseases Associated with Smoking.

20. Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey.

21. Awareness and interest in lung cancer screening among current and former smokers: findings from the ITC United States Survey.

22. US Adult Cigar Smoking Patterns, Purchasing Behaviors, and Reasons for Use According to Cigar Type: Findings From the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

23. Use of flavored electronic cigarette refill liquids among adults and youth in the US—Results from Wave 2 of the Population Assessment of Tobacco and Health Study (2014–2015).

25. Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

26. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

27. Association between use of flavoured tobacco products and quit behaviours: findings from a cross-sectional survey of US adult tobacco users.

28. US Smokers' Beliefs, Experiences and Perceptions of Different Cigarette Variants Before and After the FSPTCA Ban on Misleading Descriptors Such as "Light," "Mild," or "Low".

29. Filter presence and tipping paper color influence consumer perceptions of cigarettes.

30. The prevalence of brand switching among adult smokers in the USA, 2006-2011: findings from the ITC US surveys.

31. Associations between perceptions of e-cigarette advertising and interest in product trial amongst US adult smokers and non-smokers: results from an internet-based pilot survey.

32. Trends in the use of premium and discount cigarette brands: findings from the ITC US Surveys (2002-2011).

33. What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand.

34. Food and Drug Administration Evaluation and Cigarette Smoking Risk Perceptions.

35. Impact of Female-Oriented Cigarette Packaging in the United States.

36. Correcting Over 50 Years of Tobacco Industry Misinformation

37. The Impact of Cigarette Pack Design, Descriptors, and Warning Labels on Risk Perception in the U.S.

38. What Do Cigarette Pack Colors Communicate to Smokers in the U.S.?

39. Support and correlates of support for banning smoking in cars with children: findings from the ITC Four Country Survey*.

40. US smokers' reactions to a brief trial of oral nicotine products.

41. E-cigarette Marketing Exposure and Subsequent Experimentation Among Youth and Young Adults.

42. U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the path study.

43. Path analysis of warning label effects on negative emotions and quit attempts: A longitudinal study of smokers in Australia, Canada, Mexico, and the US.

44. Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the population assessment of tobacco and health (PATH) study.

45. Changes in the harm perceptions of different types of tobacco products for youth and adults: Waves 1-5 of the population assessment of tobacco and health (PATH) study, 2013-2019.

46. Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).

47. Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey.

48. Patterns of Premium and Nonpremium Cigar Use in the United States: Findings from Wave 6 (2021) of the Population Assessment of Tobacco and Health Study.

49. Price promotion receipt and use progression of any tobacco, cigarettes, e-cigarettes and cigars among US youth between 2016 and 2018.

50. Impact of the FDA flavour enforcement policy on flavoured electronic cigarette use behaviour changes.

Catalog

Books, media, physical & digital resources